BioMarin Expands Rare Disease Portfolio with $275 Million Acquisition of Alesta Therapeutics
The acquisition aims to enhance BioMarin's capabilities in developing innovative treatments for rare bone disorders.
Novo Nordisk CEO Stands Firm on Lawsuit Against Eli Lilly: "Fair Competition is Essential"
In a bold defense of the company's legal action, Novo Nordisk's CEO emphasizes the need for equitable practices in the burgeoning weight-loss drug market.
Novo Nordisk CEO Stands Firm on Eli Lilly Lawsuit: 'We Must Ensure Fair Competition'
In a bold defense of the company's legal action against rival Eli Lilly, Novo Nordisk's CEO emphasizes the importance of maintaining integrity in...
Novo Nordisk CEO Stands Firm in Lawsuit Against Eli Lilly: 'We Demand Fair Competition'
In a bold move, Novo Nordisk's CEO emphasizes the importance of equitable practices in the pharmaceutical industry as the company takes legal...
Trump Administration Withdraws Medicaid and CHIP Funding for Children's Gender-Affirming Care
The recent decision by the Trump administration halts federal support for gender-affirming treatments for minors through Medicaid and CHIP, while...
Trump Administration Halts Federal Funding for Children's Gender-Affirming Care in Medicaid and CHIP
The decision to cut federal dollars for gender-affirming treatments sparks a debate over state rights and the accessibility of essential...
Trump Administration Cuts Federal Funding for Gender-Affirming Care in Medicaid and CHIP
The recent decision to halt federal funding for gender-affirming care in Medicaid and CHIP raises concerns while leaving states with the option to...
Experts Warn Against Trump's Proposal to Split MMR Vaccine: A Risky Move with No Scientific Backing
Medical professionals assert that fragmenting the measles, mumps, and rubella vaccine lacks evidence and could jeopardize public health efforts.
Jazz Pharmaceuticals Boosts Rare Epilepsy Portfolio with $820 Million Acquisition of Actio Biosciences
The acquisition enhances Jazz's commitment to addressing unmet needs in rare epilepsy treatments and strengthens its position in the pharmaceutical market.
Experts Warn Against Trump's Proposal to Split MMR Vaccine Amid Health Concerns
Medical professionals emphasize that dividing the measles, mumps, and rubella vaccine lacks scientific support and could pose significant public...